Literature DB >> 26772888

Telomere length in Parkinson's disease: A meta-analysis.

Diego A Forero1, Yeimy González-Giraldo2, Catalina López-Quintero3, Luis J Castro-Vega4, George E Barreto5, George Perry6.   

Abstract

Parkinson's disease (PD) is a common and severe movement disorder. Differences in telomere length (TL) have been reported as possible risk factors for several neuropsychiatric disorders, including PD. Results from published studies for TL in PD are inconsistent, highlighting the need for a meta-analysis. In the current work, a meta-analysis of published studies for TL in PD was carried out. PubMed, Web of Science and Google Scholar databases were used to identify relevant articles that reported TL in groups of PD patients and controls. A random-effects model was used for meta-analytical procedures. The meta-analysis included eight primary studies, derived from populations of European and Asian descent, and did not show a significant difference in TL between 956 PD patients and 1284 controls (p value: 0.246). Our results show that there is no consistent evidence of shorter telomeres in PD patients and suggest the importance of future studies on TL and PD that analyze other populations and also include assessment of TL from different brain regions.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epigenomics; Meta-analysis; Movement disorders; Parkinson's disease; Telomeres

Mesh:

Year:  2016        PMID: 26772888      PMCID: PMC4786001          DOI: 10.1016/j.exger.2016.01.002

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  20 in total

1.  Telomere length and Parkinson's disease in men: a nested case-control study.

Authors:  M Schürks; J Buring; R Dushkes; J M Gaziano; R Y L Zee; T Kurth
Journal:  Eur J Neurol       Date:  2013-09-07       Impact factor: 6.089

2.  Aging-associated alteration of telomere length and subtelomeric status in female patients with Parkinson's disease.

Authors:  Toyoki Maeda; Jing Zhi Guan; Masamichi Koyanagi; Yoshihiro Higuchi; Naoki Makino
Journal:  J Neurogenet       Date:  2012-02-27       Impact factor: 1.250

Review 3.  Progress in unraveling the genetic etiology of Parkinson disease in a genomic era.

Authors:  Aline Verstraeten; Jessie Theuns; Christine Van Broeckhoven
Journal:  Trends Genet       Date:  2015-02-20       Impact factor: 11.639

4.  Study of telomere length and different markers of oxidative stress in patients with Parkinson's disease.

Authors:  G Watfa; C Dragonas; T Brosche; R Dittrich; C C Sieber; C Alecu; A Benetos; R Nzietchueng
Journal:  J Nutr Health Aging       Date:  2011-04       Impact factor: 4.075

5.  Comparison between southern blots and qPCR analysis of leukocyte telomere length in the health ABC study.

Authors:  Clara C Elbers; Melissa E Garcia; Masayuki Kimura; Steven R Cummings; Mike A Nalls; Anne B Newman; Vicki Park; Jason L Sanders; Gregory J Tranah; Sarah A Tishkoff; Tamara B Harris; Abraham Aviv
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-08-14       Impact factor: 6.053

6.  No evidence of substantia nigra telomere shortening in Parkinson's disease.

Authors:  Gavin Hudson; David Faini; Andrea Stutt; Martin Eccles; Louise Robinson; David J Burn; Patrick F Chinnery
Journal:  Neurobiol Aging       Date:  2011-07-27       Impact factor: 4.673

7.  Impartial comparative analysis of measurement of leukocyte telomere length/DNA content by Southern blots and qPCR.

Authors:  Abraham Aviv; Steven C Hunt; Jue Lin; Xiaojian Cao; Masayuki Kimura; Elizabeth Blackburn
Journal:  Nucleic Acids Res       Date:  2011-08-08       Impact factor: 16.971

8.  Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data.

Authors:  Byron C Wallace; Christopher H Schmid; Joseph Lau; Thomas A Trikalinos
Journal:  BMC Med Res Methodol       Date:  2009-12-04       Impact factor: 4.615

9.  Telomere length measurement by a novel monochrome multiplex quantitative PCR method.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

Review 10.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Authors:  Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke
Journal:  PLoS Med       Date:  2007-10-16       Impact factor: 11.069

View more
  21 in total

1.  Effect of master mixes on the measurement of telomere length by qPCR.

Authors:  Karen M Jiménez; Diego A Forero
Journal:  Mol Biol Rep       Date:  2018-04-05       Impact factor: 2.316

2.  Leukocyte Telomere Length Is Unrelated to Cognitive Performance Among Non-Demented and Demented Persons: An Examination of Long Life Family Study Participants.

Authors:  Adiba Ashrafi; Stephanie Cosentino; Min S Kang; Joseph H Lee; Nicole Schupf; Stacy L Andersen; Kaare Christensen; Michael A Province; Bharat Thyagarajan; Joseph M Zmuda; Lawrence S Honig
Journal:  J Int Neuropsychol Soc       Date:  2020-04-28       Impact factor: 2.892

3.  Retinal age gap as a predictive biomarker of future risk of Parkinson's disease.

Authors:  Wenyi Hu; Wei Wang; Yueye Wang; Yifan Chen; Xianwen Shang; Huan Liao; Yu Huang; Gabriella Bulloch; Shiran Zhang; Katerina Kiburg; Xueli Zhang; Shulin Tang; Honghua Yu; Xiaohong Yang; Mingguang He; Zhuoting Zhu
Journal:  Age Ageing       Date:  2022-03-01       Impact factor: 10.668

Review 4.  Age-Related Adaptive Immune Changes in Parkinson's Disease.

Authors:  Antonina Kouli; Caroline H Williams-Gray
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 5.  Telomere dysfunction in ageing and age-related diseases.

Authors:  Francesca Rossiello; Diana Jurk; João F Passos; Fabrizio d'Adda di Fagagna
Journal:  Nat Cell Biol       Date:  2022-02-14       Impact factor: 28.213

Review 6.  Cellular senescence in brain aging and neurodegenerative diseases: evidence and perspectives.

Authors:  Darren J Baker; Ronald C Petersen
Journal:  J Clin Invest       Date:  2018-02-19       Impact factor: 14.808

Review 7.  The Telomere/Telomerase System in Chronic Inflammatory Diseases. Cause or Effect?

Authors:  Vasileios Kordinas; Anastasios Ioannidis; Stylianos Chatzipanagiotou
Journal:  Genes (Basel)       Date:  2016-09-03       Impact factor: 4.096

Review 8.  Biological Age Predictors.

Authors:  Juulia Jylhävä; Nancy L Pedersen; Sara Hägg
Journal:  EBioMedicine       Date:  2017-04-01       Impact factor: 8.143

9.  Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis.

Authors:  Yixin Gao; Ting Wang; Xinghao Yu; Huashuo Zhao; Ping Zeng
Journal:  Sci Rep       Date:  2020-07-22       Impact factor: 4.379

10.  Telomeres as integrative markers of exposure to stress and adversity: a systematic review and meta-analysis.

Authors:  Gillian V Pepper; Melissa Bateson; Daniel Nettle
Journal:  R Soc Open Sci       Date:  2018-08-29       Impact factor: 2.963

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.